​

Alto Neuroscience (ANRO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

ANRO Stock Forecast

Alto Neuroscience (ANRO) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $16.00, with a high of $16.00 and a low of $16.00. This represents a 32.12% increase from the last price of $12.11.

- $4 $8 $12 $16 $20 High: $16 Avg: $16 Low: $16 Last Closed Price: $12.11

ANRO Stock Rating

Alto Neuroscience stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (80.00%), 1 Hold (20.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 1 4 Strong Sell Sell Hold Buy Strong Buy

ANRO Price Target Upside V Benchmarks

TypeNameUpside
StockAlto Neuroscience32.12%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts111
Avg Price Target$16.00$16.00$16.00
Last Closing Price$12.11$12.11$12.11
Upside/Downside32.12%32.12%32.12%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 25171--9
Oct, 25171--9
Sep, 25161--8
Aug, 25161--8
Jul, 25161--8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 20, 2025Robert W. Baird$16.00$11.0744.53%32.12%
Oct 23, 2024Brian SkorneyRobert W. Baird$10.00$14.53-31.18%-17.42%
Jun 20, 2024Brian SkorneyRobert W. Baird$32.00$11.11188.03%164.24%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 23, 2024WedbushOutperformNeutraldowngrade
Oct 23, 2024Rodman & RenshawBuyNeutraldowngrade
Sep 10, 2024Cowen & Co.BuyBuyhold
Sep 03, 2024WedbushOutperforminitialise
Jun 20, 2024Rodman & RenshawBuyinitialise

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.35$-2.50----
Avg Forecast$-2.93$-2.59$-2.53$-2.73$-2.52$-2.80
High Forecast$-2.93$-2.41$-2.24$-2.22$-2.23$-2.80
Low Forecast$-2.93$-2.75$-2.95$-3.38$-2.67$-2.80
Surprise %-53.92%-3.47%----

Revenue Forecast

$2M $4M $5M $7M $9M $11M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast----$10.02M$2.27M
High Forecast----$10.02M$2.27M
Low Forecast----$10.02M$2.27M
Surprise %------

Net Income Forecast

$-95M $-83M $-71M $-59M $-47M $-35M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-36.30M$-61.43M----
Avg Forecast$-78.64M$-69.39M$-77.05M$-75.32M$-65.84M$-75.21M
High Forecast$-78.64M$-64.87M$-60.12M$-59.78M$-59.90M$-75.21M
Low Forecast$-78.64M$-73.90M$-79.21M$-90.86M$-71.77M$-75.21M
Surprise %-53.83%-11.47%----

ANRO Forecast FAQ

Is Alto Neuroscience stock a buy?

Alto Neuroscience stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Alto Neuroscience is a favorable investment for most analysts.

What is Alto Neuroscience's price target?

Alto Neuroscience's price target, set by 5 Wall Street analysts, averages $16 over the next 12 months. The price target range spans from $16 at the low end to $16 at the high end, suggesting a potential 32.12% change from the previous closing price of $12.11.

How does Alto Neuroscience stock forecast compare to its benchmarks?

Alto Neuroscience's stock forecast shows a 32.12% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Alto Neuroscience over the past three months?

  • November 2025: 11.11% Strong Buy, 77.78% Buy, 11.11% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 11.11% Strong Buy, 77.78% Buy, 11.11% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 12.50% Strong Buy, 75.00% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.

What is Alto Neuroscience’s EPS forecast?

Alto Neuroscience's average annual EPS forecast for its fiscal year ending in December 2025 is $-2.53, marking a 1.20% increase from the reported $-2.5 in 2024. Estimates for the following years are $-2.73 in 2026, $-2.52 in 2027, and $-2.8 in 2028.

What is Alto Neuroscience’s revenue forecast?

Alto Neuroscience's average annual revenue forecast for its fiscal year ending in December 2025 is $0, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $0, followed by $10.02M for 2027, and $2.27M for 2028.

What is Alto Neuroscience’s net income forecast?

Alto Neuroscience's net income forecast for the fiscal year ending in December 2025 stands at $-77.05M, representing an 25.42% increase from the reported $-61.431M in 2024. Projections indicate $-75.319M in 2026, $-65.835M in 2027, and $-75.208M in 2028.